These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 15346250)

  • 1. Natural history and management of hepatitis C infection after liver transplantation.
    Charlton M; Wiesner R
    Semin Liver Dis; 2004; 24 Suppl 2():79-88. PubMed ID: 15346250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy of hepatitis C: from empiricism to eradication.
    Pawlotsky JM
    Hepatology; 2006 Feb; 43(2 Suppl 1):S207-20. PubMed ID: 16447262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with pegylated interferon and ribavirin for hepatitis C virus-associated severe cryoglobulinemia in a liver/kidney transplant recipient.
    Montalbano M; Pasulo L; Sonzogni A; Remuzzi G; Colledan M; Strazzabosco M
    J Clin Gastroenterol; 2007 Feb; 41(2):216-20. PubMed ID: 17245223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of hepatitis C reinfection with interferon-alpha2b and ribavirin after liver transplantation.
    Yedibela S; Schuppan D; Müller V; Schellerer V; Tannapfel A; Hohenberger W; Meyer T
    Liver Int; 2005 Aug; 25(4):717-22. PubMed ID: 15998420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights in recurrent HCV infection after liver transplantation.
    Hsu SH; Yeh ML; Wang SN
    Clin Dev Immunol; 2013; 2013():890517. PubMed ID: 23710205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C infection associated with renal disease and chronic renal failure.
    Poordad FF; Fabrizi F; Martin P
    Semin Liver Dis; 2004; 24 Suppl 2():69-77. PubMed ID: 15346249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent hepatitis C after liver transplantation: on-treatment prediction of response to peginterferon/ribavirin therapy.
    Hanouneh IA; Miller C; Aucejo F; Lopez R; Quinn MK; Zein NN
    Liver Transpl; 2008 Jan; 14(1):53-8. PubMed ID: 18161839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and histological efficacy of pegylated interferon and ribavirin therapy of recurrent hepatitis C after liver transplantation.
    Fernández I; Meneu JC; Colina F; García I; Muñoz R; Castellano G; Fuertes A; Abradelo M; Lumbreras C; Moreno E; Solís-Herruzo JA
    Liver Transpl; 2006 Dec; 12(12):1805-12. PubMed ID: 17133585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current treatment of hepatitis C virus infection].
    Lörke J; Avci A; Erhardt A; Heintges T; Häussinger D
    Dtsch Med Wochenschr; 2005 Jul; 130(30):1773-7. PubMed ID: 16049884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study.
    Samuel D; Bizollon T; Feray C; Roche B; Ahmed SN; Lemonnier C; Cohard M; Reynes M; Chevallier M; Ducerf C; Baulieux J; Geffner M; Albrecht JK; Bismuth H; Trepo C
    Gastroenterology; 2003 Mar; 124(3):642-50. PubMed ID: 12612903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controversies in the management of hepatitis C virus infection after liver transplantation.
    Shiffman ML; Vargas HE; Everson GT
    Liver Transpl; 2003 Nov; 9(11):1129-44. PubMed ID: 14586872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practical management of liver transplant recipients for hepatitis C.
    Saab S; Busuttil RW
    Minerva Chir; 2003 Aug; 58(4):479-89. PubMed ID: 14603160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of recurrent hepatitis C infection after liver transplantation with combination of pegylated interferon alpha2b and ribavirin: an open-label series.
    Rodriguez-Luna H; Khatib A; Sharma P; De Petris G; Williams JW; Ortiz J; Hansen K; Mulligan D; Moss A; Douglas DD; Balan V; Rakela J; Vargas HE
    Transplantation; 2004 Jan; 77(2):190-4. PubMed ID: 14742979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of sustained virological response in liver transplant recipients with recurrent hepatitis C virus following combination pegylated interferon alfa-2b and ribavirin therapy using tissue hepatitis C virus reverse transcriptase polymerase chain reaction testing.
    Neff GW; O'Brien CB; Cirocco R; Montalbano M; de Medina M; Ruiz P; Khaled AS; Bejarano PA; Safdar K; Hill MA; Tzakis AG; Schiff ER
    Liver Transpl; 2004 May; 10(5):595-8. PubMed ID: 15108250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pegylated interferon plus ribavirin for recurrent Hepatitis C infection after liver transplantation in naïve and non-responder patients on a stable immunosuppressive regimen.
    Biselli M; Andreone P; Gramenzi A; Lorenzini S; Loggi E; Bonvicini F; Cursaro C; Bernardi M
    Dig Liver Dis; 2006 Jan; 38(1):27-32. PubMed ID: 16311084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of interferon in immunocompromised HCV patients after liver transplantation or with HIV co-infection.
    Reiberger T; Rasoul-Rockenschaub S; Rieger A; Ferenci P; Gangl A; Peck-Radosavljevic M
    Eur J Clin Invest; 2008 Jun; 38(6):421-9. PubMed ID: 18489402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus in the setting of HIV or hepatitis B virus coinfection.
    Sterling RK; Sulkowski MS
    Semin Liver Dis; 2004; 24 Suppl 2():61-8. PubMed ID: 15346248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, double-blind, placebo-controlled study of peginterferon alfa-2a (40KD) plus ribavirin with or without amantadine in treatment-naïve patients with chronic hepatitis C genotype 1 infection.
    Ferenci P; Formann E; Laferl H; Gschwantler M; Hackl F; Brunner H; Hubmann R; Datz C; Stauber R; Steindl-Munda P; Kessler HH; Klingler A; Gangl A;
    J Hepatol; 2006 Feb; 44(2):275-82. PubMed ID: 16338019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of chronic hepatitis C in children.
    González-Peralta RP
    Pediatr Transplant; 2004 Dec; 8(6):639-43. PubMed ID: 15598340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of fatty liver and related factors on the efficacy of combination antiviral therapy in patients with chronic hepatitis C.
    Jian Wu Y; Shu Chen L; Gui Qiang W
    Liver Int; 2006 Mar; 26(2):166-72. PubMed ID: 16448454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.